Month: May 2021

Related Products of 68-04-2, Enzymes are biological catalysts that produce large increases in reaction rates and tend to be specific for certain reactants and products. 68-04-2, Name is Sodium citrate, SMILES is O=C(CC(C([O-])=O)(O)CC([O-])=O)[O-].[Na+].[Na+].[Na+], belongs to benzisoxazole compound. In a article, author is Sawant-Basak, Aarti, introduce new discover of the category.

4-{4-[4-Tetrahydrofuran-3-yloxy)-benzo[d]isoxazol-3-yloxymethyl]-piperidin-1-ylmethyl}-tetrahydropyran-4-ol (PF-4995274, TBPT) is a new agent that is a partial agonist of the human serotonin-4 (5-HT4) receptor and is under investigation for neurological disorders. Metabolism of TBPT was examined in vitro in human liver microsomes and human hepatocytes. Metabolites were also identified in the plasma of healthy human subjects in a phase 1 clinical study. Human-derived metabolite profiles were compared with corresponding profiles obtained in laboratory animal species. There were two major routes of metabolism in vitro: N-dealkylation of the methyltetrahydropyran moiety (M1) and hydroxylation at the seven position of the benzisoxazole moiety (M4). These were also observed in human plasma; however, in that matrix, the major metabolite was an unusual cyclized oxazolidine entity (M2). M2 was proposed to be formed via generation of an intermediate 4. iminium ion on the piperidine ring followed by spontaneous cyclization by attack of the beta-hydroxyl substituent of the tetrahydropyran ring to form a cyclized oxazolidine product. An authentic standard of the metabolite was generated using a methylene-blue-sensitized photochemical oxidation reaction as well as microbial transformation. Further investigation of this metabolite showed that it also possessed 5-HT4 agonism activity similar to the parent. The metabolite was 150-fold more highly protein bound in human plasma than TBPT, which is consistent with its presence as a major circulating metabolite while being only a minor metabolite in in vitro systems. Overall, this illustrates the importance of understanding the complex dispositional properties of a pharmacologically active metabolite. (C) 2013 Wiley Periodicals, Inc.

Related Products of 68-04-2, The reactant in an enzyme-catalyzed reaction is called a substrate. Enzyme inhibitors cause a decrease in the reaction rate of an enzyme-catalyzed reaction.I hope my blog about 68-04-2 is helpful to your research.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

Chemistry is the experimental and theoretical study of materials on their properties at both the macroscopic and microscopic levels. 701-97-3, Name is 3-Cyclohexylpropionic Acid, molecular formula is C9H16O2. In an article, author is Patel, J. M.,once mentioned of 701-97-3, Product Details of 701-97-3.

The present investigation reports the synthesis of new furobenzisoxazole derivatives. Posner reaction of hydroxyfurocoumarin has been studied, wherein the two reaction products are identified as 5-methylfuro[2′,3′: 4,5] benzo[ 1,2-d] isoxazol-3-yl) acetic acid and 1-(6- hydroxy- 3- methylbenzofuran5- yl) ethanone oxime, depending on the conditions used. 1,3,4- Oxadiazole, 2- mercapto- 1,3,4- oxadiazole and thiazolidinone derivatives of furobenzisoxazole were synthesized from hydrazide.

If you’re interested in learning more about 701-97-3. The above is the message from the blog manager. Product Details of 701-97-3.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

Application of 2836-32-0, Enzymes are biological catalysts that produce large increases in reaction rates and tend to be specific for certain reactants and products. 2836-32-0, Name is Sodium glycolate, SMILES is OCC([O-])=O.[Na+], belongs to benzisoxazole compound. In a article, author is GenreGrandpierre, A, introduce new discover of the category.

Rather efficient catalysis of the decomposition of 5-nitro-benzisoxazole to the cyanophenol was observed with antibodies elicited against a cationic hapten structurally unrelated to the benzisoxazole substrate. The rate enhancement by the most active antibody is better than 10(4) and the reaction is catalyzed by a carboxylate group associated with a hydrophobic binding site. (C) 1997 Elsevier Science Ltd.

Application of 2836-32-0, One of the oldest and most widely used commercial enzyme inhibitors is aspirin, which selectively inhibits one of the enzymes involved in the synthesis of molecules that trigger inflammation. you can also check out more blogs about 2836-32-0.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

Application of 503-74-2, Enzymes are biological catalysts that produce large increases in reaction rates and tend to be specific for certain reactants and products. 503-74-2, Name is 3-Methylbutanoic acid, SMILES is CC(C)CC(O)=O, belongs to benzisoxazole compound. In a article, author is Safaei-Ghomi, Javad, introduce new discover of the category.

A quick and convenient method for the preparation of 2-aminobenzophenone derivatives is described. This approach consists of the nucleophilic substitution reaction of nitrobenzenes by phenylacetonitrile under conventional and ultrasonic conditions followed by reduction of the produced 2,1-benzisoxazole to 2-aminobenzophenone. This 2-step reaction was studied by changing the reaction parameters (reaction temperature, ultrasound power, and reaction time). The results clearly demonstrated that using ultrasound irradiation results in a high yield within a short reaction time.

Application of 503-74-2, Each elementary reaction can be described in terms of its molecularity, the number of molecules that collide in that step. The slowest step in a reaction mechanism is the rate-determining step.you can also check out more blogs about 503-74-2.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

Application of 546-89-4, Chemo-enzymatic cascade processes are invaluable due to their ability to rapidly construct high-value products from available feedstock chemicals in a one-pot relay manner. 546-89-4, Name is Lithiumacetate, SMILES is CC([O-])=O.[Li+], belongs to benzisoxazole compound. In a article, author is BRANCA, C, introduce new discover of the category.

In order to understand better the relationship between auxin structure and activity on morphogenesis and cell elongation, six different auxins were tested on the regeneration of tomato (Lycopersicon esculentum Miller var. Alice) from cotyledons and on pea (Pisum sativum L. var. Alaska) stem elongation. The auxins were: indole-3-acetic acid (IAA), indole-3-butyric acid (IBA), 1, 2-benzisoxazole-3-acetic acid (BOA), 1,2-benzisothiazole-3-acetic acid (BIA), 1-naphthalenacetic acid (NAA), 2,4-dichlorophenoxyacetic acid (2,4-D). All these compounds obey the minimum requirement rules for auxin activity and all were effective on cell elongation. At the dose of 10-mu-M and in the absence of cytokinin, they all, except 2,4-D, induced roots, while in the presence of cytokinin they induced shoots, roots, hairy root-like filaments (HRLF) or callus depending on their concentration. The morphogenetic pattern did not change by varying cytokinin concentration. We conclude that auxin structure plays a minor role in morphogenesis or cell elongation, because it is only responsible for variations in the level of auxin activity.

Application of 546-89-4, Each elementary reaction can be described in terms of its molecularity, the number of molecules that collide in that step. The slowest step in a reaction mechanism is the rate-determining step.you can also check out more blogs about 546-89-4.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

Catalysts are substances that increase the reaction rate of a chemical reaction without being consumed in the process. 625-08-1, Name is 3-Hydroxy-3-methylbutanoic acid, SMILES is CC(C)(O)CC(O)=O, belongs to benzisoxazole compound. In a document, author is JOSHI, KC, introduce the new discover, Product Details of 625-08-1.

Reactions of fluorinated 3-(2-oxocycloalkylidene)indol-3(1H)-ones (1) with 4-fluorophenylsulphonyl hydrazide in ethanolic KOH yielded spiro[3H-indazole-3,3′(3H)-indole]-2′(1’H)-ones (2a, b; n = 2) and spiro[3H-indole-3,3′(3H)-pyrazol]-2(1H)-ones (2c; n = 1). Further, the reaction of 1 with hydroxylamine hydrochloride in dry pyridine in the presence of fused sodium acetate yielded some new 2,3a,4,5,6,7-hexahydro[spiro-3H-benzisoxazole-3,3′(3H)-indol]-2′(1’H)-ones (3a, b; n = 2) and 4′,5′-cyclopentaspiro[3H-indole-3,3′(3H)-isoxaazol]-2(1H)-ones (3c, d; n = 1). The nonfluorinated analog gave 3-(2-oxocycloalkylidene)-2′-oximeindole-2(1H)-one (4a) in addition to the spiro compound (3a). All the compounds have been characterised from their analytical and ir, pmr, C-13 nmr, F-19 nmr and mass spectral data.

The proportionality constant is the rate constant for the particular unimolecular reaction. the reaction rate is directly proportional to the concentration of the reactant. I hope my blog about 625-08-1 is helpful to your research. Product Details of 625-08-1.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

In an article, author is Steinhoff, B. J., once mentioned the application of 3878-55-5, Name is 4-Methoxy-4-oxobutanoic acid, molecular formula is C5H8O4, molecular weight is 132.12, MDL number is MFCD00002788, category is benzisoxazole. Now introduce a scientific discovery about this category, Recommanded Product: 3878-55-5.

Zonisamide (ZNS) is a benzisoxazole derivate not structurally related to currently licensed antiepileptic drugs. It has multiple modes of action whose impact on the anticonvulsant effect is not yet fully understood: ZNS interrupts the synchronized neuronal firing through direct effects on voltage-dependent sodium and T-type calcium channels. Thus epileptiform propagation and activity are blocked. Furthermore ZNS has a modulating effect on the GABAergic inhibition, and may act on the dopaminergic and serotonergic neurotransmission and on acetylcholine pathways. An inhibition of excitatory glutamatergic transmission by reduction of the presynaptic release of glutamate has been also described. These modes of action suggest a broad anticonvulsant efficacy.

Do you like my blog? If you like, you can also browse other articles about this kind. Thanks for taking the time to read the blog about 3878-55-5, Recommanded Product: 3878-55-5.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

Electric Literature of 18996-35-5, Catalysts allow a reaction to proceed via a pathway that has a lower activation energy than the uncatalyzed reaction. 18996-35-5, Name is Sodium 3,4-dicarboxy-3-hydroxybutanoate, SMILES is OC(C(O)=O)(CC([O-])=O)CC(O)=O.[Na+], belongs to benzisoxazole compound. In a article, author is Clausen, RP, introduce new discover of the category.

The system of GABA transporters in neural cells constitutes an efficient mechanism for terminating inhibitory GABAergic neurotransmission. This transport system is an important therapeutical target in epileptic disorders, but potentially also in other neurological disorders. Thus, selective intervention in GABA uptake has been the subject of extensive research for several decades. In a series of lipophilic diaromatic derivatives of (RS)3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole (exo-THPO), N-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-hydroxy-4-(methylamino)4,5,6,7-tetrahydrobenzo[d]isoxazol-3-ol (EF1502) turned out to be an equipotent inhibitor at the mouse transporters GAT1 and GAT2 (BGT-1) but inactive at GAT3 and GAT4. This novel pharmacological profile among GABA uptake inhibitors prompted a thorough investigation of the in vivo properties of this compound. These investigations have for the first time demonstrated a functional role for GABA transporter subtype GAT2/ BGT-1, which points to the therapeutic relevance of inhibiting this transporter subtype. An overview of the development and characterisation of EF1502 is presented here. (C) 2006 Elsevier Ltd. All rights reserved.

Electric Literature of 18996-35-5, Each elementary reaction can be described in terms of its molecularity, the number of molecules that collide in that step. The slowest step in a reaction mechanism is the rate-determining step.you can also check out more blogs about 18996-35-5.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 2836-32-0, Name is Sodium glycolate, molecular formula is C2H3NaO3. In an article, author is Sawant-Basak, Aarti,once mentioned of 2836-32-0, Safety of Sodium glycolate.

4-{4-[4-Tetrahydrofuran-3-yloxy)-benzo[d]isoxazol-3-yloxymethyl]-piperidin-1-ylmethyl}-tetrahydropyran-4-ol (PF-4995274, TBPT) is a new agent that is a partial agonist of the human serotonin-4 (5-HT4) receptor and is under investigation for neurological disorders. Metabolism of TBPT was examined in vitro in human liver microsomes and human hepatocytes. Metabolites were also identified in the plasma of healthy human subjects in a phase 1 clinical study. Human-derived metabolite profiles were compared with corresponding profiles obtained in laboratory animal species. There were two major routes of metabolism in vitro: N-dealkylation of the methyltetrahydropyran moiety (M1) and hydroxylation at the seven position of the benzisoxazole moiety (M4). These were also observed in human plasma; however, in that matrix, the major metabolite was an unusual cyclized oxazolidine entity (M2). M2 was proposed to be formed via generation of an intermediate 4. iminium ion on the piperidine ring followed by spontaneous cyclization by attack of the beta-hydroxyl substituent of the tetrahydropyran ring to form a cyclized oxazolidine product. An authentic standard of the metabolite was generated using a methylene-blue-sensitized photochemical oxidation reaction as well as microbial transformation. Further investigation of this metabolite showed that it also possessed 5-HT4 agonism activity similar to the parent. The metabolite was 150-fold more highly protein bound in human plasma than TBPT, which is consistent with its presence as a major circulating metabolite while being only a minor metabolite in in vitro systems. Overall, this illustrates the importance of understanding the complex dispositional properties of a pharmacologically active metabolite. (C) 2013 Wiley Periodicals, Inc.

Interested yet? Keep reading other articles of 2836-32-0, you can contact me at any time and look forward to more communication. Safety of Sodium glycolate.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

Chemistry, like all the natural sciences, begins with the direct observation of nature— in this case, of matter.532-32-1, Name is Sodium benzoate, SMILES is O=C([O-])C1=CC=CC=C1.[Na+], belongs to benzisoxazole compound. In a document, author is Chen, Yin, introduce the new discover, Product Details of 532-32-1.

In this paper, we report the optimization of a series of novel, potential antipsychotic derivatives combining potent dopamine D-2, D-3 and serotonin 5-HT1A, 5-HT2A receptor affinities. The pharmacological features of compound 27 are a high affinity for dopamine D-2, D-3 and serotonin 5-HT1A, 5-HT2A receptors. Moreover it possesses low affinity for 5-HT2C and H-1 receptors (to reduce the risk of obesity associated with chronic treatment) and hERG channels (to reduce the incidence of torsade des pointes). Furthermore, compound 27 inhibited apomorphine-induced climbing, MK-801-induced hyperactivity and DOI-induced head twitch without observable catalepsy at the highest dose tested in mice. Taken together, among the amide derivatives, we identified compound 27 as a potential antipsychotic lead candidate.

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions. you can also check out more blogs about 532-32-1. Product Details of 532-32-1.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics